Daily non-political popular news in brief.
Chemo drugs for treating breast cancer may cause changes in cognitive function
10-27-2006 · EurekAlert!A new study investigating the effects of chemotherapy on cognitive function in mice has confirmed what many cancer patients receiving treatment have often complained about -- a decline in their memory and other cognitive functions, sometimes characterized as "chemobrain."
Read more »
Keywords: chemo, drugs, treating, breast, cancer, cause, changes, cognitive, function, drug, change
« Previous | Next »
Similar news on "Chemo drugs for treating breast cancer may cause changes in cognitive function":
- Other highlights in the Dec. 6 JNCI
12-05-2006 · EurekAlert!
Other highlights in the Dec. 6 JNCI include an Italian model that predicts the risk of breast cancer, a study showing chemotherapy can cause a cognitive decline in some patients, a common genetic variant that is linked to drug-induced diarrhea, a protein that signals poor prognosis in some breast cancer patients and specific genetic changes that are linked to colon cancer in smokers.
Similar news · Read more »
- Brain-boosting pill alleviates post-chemotherapy fogginess
06-03-2007 · EurekAlert!
A drug described by some people as a "genius pill" for enhancing cognitive function provided relief to a small group of Rochester breast cancer survivors who were coping with a side effect known as "chemo-brain," according to a University of Rochester Medical Center study.
Similar news · Read more »
- Chemo combo fights cancer
11-23-2006 · EurekAlert!
Bacteria that can cause deadly infections in humans and animals have shown promise in treating cancer by "eating" tumors from the inside out. Now, two new studies at the Johns Hopkins Kimmel Cancer Center have demonstrated that, combined with specially-packaged anti-cancer drugs, the bacterial therapy's prospects for cancer eradication have dramatically improved.
Similar news · Read more »
- Chemotherapy temporarily affects the structures of the human brain
11-27-2006 · EurekAlert!
Researchers have linked chemotherapy with short-term structural changes in cognitive areas of the brain, according to a new study. The study reveals that within 12 months of receiving adjuvant chemotherapy, significant regions of the brain associated with memory, analysis and other cognitive functions were significantly smaller in breast cancer patients who received chemotherapy than those who did not.
Similar news · Read more »
- Ireland Cancer Center researcher finds standard treatment for breast cancer not followed
12-21-2007 · EurekAlert!
Research out of the Ireland Cancer Center of University Hospitals Case Medical Center, in collaboration with six integrated health plans that are part of the Cancer Research Network, found that the majority of older women with early stage breast cancer fail to adhere to the standard of treatment -- five years of daily oral use of the chemo-prevention drug Tamoxifen.
Similar news · Read more »
- New angiogenesis inhibitor has promise for treating deadly brain tumor
01-16-2007 · EurekAlert!
Researchers from the Massachusetts General Hospital Cancer Center have found that AZD2171, a new angiogenesis inhibitor, can significantly reduce the size of the deadly brain tumors called glioblastomas and has the potential of improving the effectiveness of other therapeutic techniques. The Phase 2 clinical trial also finds that the new drug can alleviate brain swelling (edema), a debilitating symptom in many brain cancer patients that currently can be treated only with steroid drugs.
Similar news · Read more »
- Promising drug combination may help those with ocular melanoma that has spread
09-04-2007 · EurekAlert!
A combination of two drugs shows promise in treating a rare and therapy-resistant type of melanoma that originates in the eye and spreads to other organs, according to a new study led by Duke University Comprehensive Cancer Center researchers.
Similar news · Read more »
- JCI table of contents -- April 19, 2007
04-19-2007 · EurekAlert!
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, April 19, 2007, in the JCI, including: Why cisplatin kills breast cancer cells when other drugs fail; Why don’t mothers’ bodies reject their fetus?; Understanding how glucocorticoids work to stop skin irritation; Filling in the blanks: MAPKs mediate heart function defects in Emery-Dreifuss muscular dystrophy; and others.
Similar news · Read more »
- Annals of Internal Medicine tip sheet for Oct. 2
10-01-2007 · EurekAlert!
The following press releases are attached to the upcoming issue of Annals of Internal Medicine: "Organizations Issue Comprehensive Guidelines for Treating Low Back Pain: Clinicians Shouldn't Routinely Order Imaging and Other Diagnostic Tests"; "Trial of Two Drugs Finds One Better at Suppressing Hepatitis B Virus"; and "All Screening Models for Breast Cancer-Causing Gene Mutations Work, with Reservations."
Similar news · Read more »
- Enzyme structure reveals new drug targets for cancer and other diseases
02-14-2008 · EurekAlert!
Researchers now have a clearer understanding of how a key protein controls gene activity and how mutations in the protein may cause disease. The work could provide new avenues to design drugs aimed at cancer, diabetes, HIV, and heart disease.
Similar news · Read more »
